Zobrazeno 1 - 8
of 8
pro vyhledávání: '"A M Cafro"'
Autor:
A. Larocca, M. D’Agostino, N. Giuliani, E. Antonioli, R. Zambello, S. Ronconi, I. D. Vincelli, F. Ciceri, A. P. Falcone, M. Michieli, F. Cattel, A. Capra, M. Grasso, A. M. Cafro, F. Bonello, R. Floris, M. Offidani, E. Sciorsi, G. Pietrantuono, P. Curci, F. Patriarca, M. Cavo, S. Mangiacavalli, G. Benevolo, A. Evangelista, G. Ciccone, M. Boccadoro, B. Bruno, S. Bringhen
Publikováno v:
HemaSphere, Vol 7, Iss S2, Pp 12-13 (2023)
Externí odkaz:
https://doaj.org/article/08cabf322f26474cbfdd0b80f6ff0a58
Autor:
M. S. Raab, Y. C. Cohen, F. Schjesvold, K. Aardalen, A. Oka, A. Spencer, M. Wermke, P. Hari, J. L. Kaufman, A. M. Cafro, E. M. Ocio, N. Doki, K. Henson, G. Trabucco, P.-E. Juif, R. Chawla, J. Cotton, A. Fessehatsion, L. Fan, J. Blankenship, B. Granda, H. Lu, S. De Vita
Publikováno v:
HemaSphere, Vol 6, Pp 827-828 (2022)
Externí odkaz:
https://doaj.org/article/ae21d2616bf84baa81310ce308b342f9
Autor:
F Gay, S Oliva, M T Petrucci, V Montefusco, C Conticello, P Musto, L Catalano, A Evangelista, S Spada, P Campbell, R Ria, M Salvini, M Offidani, A M Carella, P Omedé, A M Liberati, R Troia, A M Cafro, A Malfitano, A P Falcone, T Caravita, F Patriarca, A Nagler, A Spencer, R Hajek, A Palumbo, M Boccadoro
In newly diagnosed myeloma patients, upfront autologous transplant (ASCT) prolongs progression-free survival 1 (PFS1) compared with chemotherapy plus lenalidomide (CC+R). Salvage ASCT at first relapse may still effectively rescue patients who did not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84c4f647079b6103a7ce67e8fc9fee59
http://hdl.handle.net/2318/1678934
http://hdl.handle.net/2318/1678934
Autor:
Jennifer Herring, Latisha Watkins, Neil Miller, Michele Cavo, Paolo Corradini, Mohamed H. Zaki, Enrique M. Ocio, Stefan Knop, Philippe Moreau, Katja Weisel, A. M. Cafro, Mathew Simcock, Michel Delforge, Ana Slaughter, Antonio Palumbo, Tsvetan Biyukov, Felipe de Arriba, Meletios A. Dimopoulos, Teresa Peluso, Christoph Röllig
Publikováno v:
Blood. 126:1834-1834
Introduction: The introduction of newer agents, such as lenalidomide (LEN) and bortezomib (BORT), has resulted in improved survival outcomes in pts with RRMM (Kumar, Leukemia, 2012), and a greater depth of response has been associated with improved e
Autor:
Mario Boccadoro, Dina Ben-Yehuda, Pellegrino Musto, Elisabetta Calabrese, Antonio Palumbo, M.T. Petrucci, Nicola Cascavilla, A. M. Cafro, Arnon Nagler, Francesca Patriarca, Anna Marina Liberati, Barbara Lupo, Giuseppe Milone, Fausto Rossini, Claudia Crippa, Roberto Passera, Vittorio Montefusco, Paola Omedè, Sara Bringhen, Federica Cavallo, Jacopo Peccatori, Tommaso Caravita, Lucio Catalano, A. M. Carella
Publikováno v:
Leukemia. 25(10)
Lenalidomide has raised concerns regarding its potential impact on the ability to collect stem cells for autologous stem cell transplantation, especially after prolonged exposure. The use of cyclophosphamide plus granulocyte colony-stimulating factor
Autor:
A. Benini, Carlo Maurizio Camaggi, Elena Strocchi, A. M. Cafro, M. Montillo, L. Intropido, E. Morra, A. Tedeschi
Publikováno v:
Haematology and Blood Transfusion Hämatologie und Bluttransfusion ISBN: 9783642639494
Induction regimens currently used in acute lymphoblastic leukemia (ALL) result in complete remission (CR) for 65–85% of adult patients (Weiss et al 1996, Larson et al 1995, Hoelzer 1993). Unfortunately only 20 to 30% of all patients will be cured f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9a820243cf4de568f0fce17757df2cc
https://doi.org/10.1007/978-3-642-59358-1_76
https://doi.org/10.1007/978-3-642-59358-1_76
Autor:
Angelo Michele Carella, Sara Pezzatti, Michele Cavo, Francesca Patriarca, Moshe Levin, A. M. Cafro, Mario Boccadoro, Davide Rossi, Norbert Pescosta, Paolo Corradini, Anna Baraldi, Monica Galli, Sara Grammatico, Roberto Ria, Claudia Crippa, Barbara Lupo, Valter Redoglia, Maide Cavalli, Arnon Nagler, Giulia Benevolo, Antonio Palumbo, Clotilde Cangialosi, Tommaso Caravita di Toritto, Antonietta Falcone, Magda Marcatti, Federica Cavallo, Izhar Hardan, Francesco Di Raimondo, Agostina Siniscalchi, Lucio Catalano
Publikováno v:
Blood. 118:3069-3069
Abstract 3069FN2 Background: High-dose chemotherapy with haemopoietic stem-cell improves outcome in multiple myeloma (MM). The introduction of novel agents questions the role of autologous stem-cell transplantation (ASCT) in MM patients. Aims: In thi
Autor:
Stephanie Vauléon, Katja Weisel, D Zboralski, Xavier Leleu, C. Leitgeb, Richard Greil, A. M. Cafro, M.T. Petrucci, Anna Kruschinski, Ibrahim Yakoub-Agha, Thomas Dümmler, Robert Foa, Matthias Baumann, Kai Riecke, Heinz Ludwig, Diana Beyer, Monika Engelhardt, Laurent Garderet
Publikováno v:
Leukemia
Olaptesed pegol (olaptesed, NOX-A12) is a pegylated l-oligoribonucleotide that binds and neutralizes CXCL12, a chemokine which signals through CXCR4 and CXCR7 regulating a variety of processes during multiple myeloma (MM) development.1 CXCL12 inhibit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43cbe42033cd3029e4d5e46c73263687
http://hdl.handle.net/11573/935129
http://hdl.handle.net/11573/935129